© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
Conversations at The Family Medicine Experience (FMX) 2025: John Anderson, MD and Charles Vega, MD
October 13, 2025
Anderson and Vega discuss CGM use in primary care, obesity management, immunization challenges, and cognitive decline in older adults.
WHO: 1 in 6 Common Infections Now Drug-Resistant, AMR Threatens Global Health
October 13, 2025
New global WHO data show escalating resistance in key bacterial pathogens, threatening frontline antibiotics and narrowing treatment options worldwide.
Cancer Screening Updates Every Primary Care Clinician Should Know
October 10, 2025
From dense breast notification laws to changing lung and cervical screening criteria, experts share practical strategies to help navigate today’s evolving cancer prevention landscape.
Vaccines, Policy, and the Erosion of Trust: A Conversation with Chuck Vega, MD
October 10, 2025
Vega considers the impact of recent changes in immunization policy on trust not just among patients but among clinicians as well. It all threatens good patient care, he said.
Telemedicine Improves Inhaler Technique, QoL Following Severe Exacerbation of COPD
October 10, 2025
Telemedicine follow-up after hospital discharge for COPD exacerbation was significantly more effective than standard care and received high patient satisfaction scores.
Johnson & Johnson Rolls Out Data From Major Depressive Disorder Portfolio at ECNP
October 10, 2025
Clinical and real-world data are on deck for lumateperone, seltorexant, and esketamine to treat major depressive disorder and treatment-resistant depression.
Open-Label Placebos Show Mixed Results in Migraine Prevention Trial
October 10, 2025
OLPs did not affect migraine frequency but did subjectively improve QoL, with authors noting they may have a role as a supportive treatment option for select patients.
Top Takeaways From FMX 2025: What Primary Care Physicians Can Put Into Practice Now
October 10, 2025
Practical insights from FMX 2025 to help primary care physicians apply new evidence, guidelines, and patient-care strategies in daily practice.
The Frist Clinic's John Anderson, MD, on Making CGM Metrics Work With Type 2 Diabetes Patients
October 09, 2025
Time in range, glucose variability, and postprandial spikes: Anderson highlights how CGM insights translate quickly into targeted treatment decisions.
FDA Approves Nerandomilast, First New IPF Treatment in More Than a Decade
October 08, 2025
Approval of the novel oral PDE4B inhibitor offers hope to individuals with the rare, chronic, and progressive pulmonary disease for which treatment options are few.